APPLICATION
ANDA071247
TYPE
ANDA
LATEST ACTION
1988-12-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LORAZEPAMDiscontinued
LORAZEPAM 2MG · TABLET · ORAL
Approval history
1988-12-23Labeling · Supplement 3AP
1988-09-27Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.